Preeclampsia is associated with a reduced response to activated protein C
- 28 February 1997
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 176 (2), 457-460
- https://doi.org/10.1016/s0002-9378(97)70515-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1995
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Inherited resistance to activated protein C iscorrected by anticoagulant cofactor activity found to be a property of factorV.Proceedings of the National Academy of Sciences, 1994
- The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsBlood Coagulation & Fibrinolysis, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Acute atherosis in preeclampsia: Maternal determinants and fetal outcome in the presence of the lesionAmerican Journal of Obstetrics and Gynecology, 1987
- THE ULTRASTRUCTURE OF THE ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN PREGNANCY COMPLICATED BY FETAL GROWTH RETARDATIONBJOG: An International Journal of Obstetrics and Gynaecology, 1976